Mechanisms of Antimicrobial Peptide Action and Resistance

Antimicrobial peptides have been isolated and characterized from tissues and organisms representing virtually every kingdom and phylum, ranging from prokaryotes to humans. Yet, recurrent structural and functional themes in mechanisms of action and resistance are observed among peptides of widely diverse source and composition. Biochemical distinctions among the peptides themselves, target versus host cells, and the microenvironments in which these counterparts convene, likely provide for varying degrees of selective toxicity among diverse antimicrobial peptide types. Moreover, many antimicrobial peptides employ sophisticated and dynamic mechanisms of action to effect rapid and potent activities consistent with their likely roles in antimicrobial host defense. In balance, successful microbial pathogens have evolved multifaceted and effective countermeasures to avoid exposure to and subvert mechanisms of antimicrobial peptides. A clearer recognition of these opposing themes will significantly advance our understanding of how antimicrobial peptides function in defense against infection. Furthermore, this understanding may provide new models and strategies for developing novel antimicrobial agents, that may also augment immunity, restore potency or amplify the mechanisms of conventional antibiotics, and minimize antimicrobial resistance mechanisms among pathogens. From these perspectives, the intention of this review is to illustrate the contemporary structural and functional themes among mechanisms of antimicrobial peptide action and resistance.

[1]  M. Teuber,et al.  Induction of polymyxin resistance in Pseudomonas fluorescens by phosphate limitation , 1977, Archives of Microbiology.

[2]  J. Bader,et al.  Action of polymyxin B on bacterial membranes , 1976, Archives of Microbiology.

[3]  M. Teuber Action of polymyxin B on bacterial membranes , 2004, Archives of Microbiology.

[4]  P. Axelsen,et al.  Transcriptional Profile of the Escherichia coli Response to the Antimicrobial Insect Peptide Cecropin A , 2003, Antimicrobial Agents and Chemotherapy.

[5]  M. Selsted,et al.  Antimicrobial Peptides from Human Platelets , 2002, Infection and Immunity.

[6]  Michael R. Yeaman,et al.  Synthetic Peptides That Exert Antimicrobial Activities in Whole Blood and Blood-Derived Matrices , 2002, Antimicrobial Agents and Chemotherapy.

[7]  John A. Robinson,et al.  Macrocyclic Hairpin Mimetics of the Cationic Antimicrobial Peptide Protegrin I: A New Family of Broad‐Spectrum Antibiotics , 2002, Chembiochem : a European journal of chemical biology.

[8]  Ø. Samuelsen,et al.  Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. , 2002, The Journal of antimicrobial chemotherapy.

[9]  E. Dalmasso,et al.  Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor , 2002, Science.

[10]  C. Nast,et al.  Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. , 2002, The Journal of infectious diseases.

[11]  Samuel I. Miller,et al.  mig-14 Is a Salmonella Gene That Plays a Role in Bacterial Resistance to Antimicrobial Peptides , 2002, Journal of bacteriology.

[12]  K. Matsuzaki,et al.  Specific interactions of the antimicrobial peptide cyclic beta-sheet tachyplesin I with lipopolysaccharides. , 2002, Biochimica et biophysica acta.

[13]  A. Bayer,et al.  Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins. , 2002, The Journal of infectious diseases.

[14]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[15]  S. Miller,et al.  Lipid A Modifications in Polymyxin-resistant Salmonella typhimurium , 2001, The Journal of Biological Chemistry.

[16]  K. Matsuzaki,et al.  Bacteria-selective synergism between the antimicrobial peptides alpha-helical magainin 2 and cyclic beta-sheet tachyplesin I: toward cocktail therapy. , 2001, Biochemistry.

[17]  M. Palmer,et al.  The family of thiol-activated, cholesterol-binding cytolysins. , 2001, Toxicon : official journal of the International Society on Toxinology.

[18]  Nanne Nanninga,et al.  Escherichia coli Minicell Membranes Are Enriched in Cardiolipin , 2001, Journal of bacteriology.

[19]  A. Peschel,et al.  Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin , 2001, Peptides.

[20]  Y. Shai,et al.  From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides , 2001, Peptides.

[21]  T. Tachi,et al.  Heterodimer formation between the antimicrobial peptides magainin 2 and PGLa in lipid bilayers: a cross-linking study. , 2001, Biochemistry.

[22]  R. Hancock,et al.  Interaction of Cationic Antimicrobial Peptides with Model Membranes* , 2001, The Journal of Biological Chemistry.

[23]  D. Rijkers,et al.  Membrane-Spanning Peptides Induce Phospholipid Flop: A Model for Phospholipid Translocation across the Inner Membrane of E. coli , 2001 .

[24]  L. Yang,et al.  Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.

[25]  D. Kim,et al.  Internalization of tenecin 3 by a fungal cellular process is essential for its fungicidal effect on Candida albicans. , 2001, European journal of biochemistry.

[26]  A. Bayer,et al.  Diversity in Antistaphylococcal Mechanisms among Membrane-Targeting Antimicrobial Peptides , 2001, Infection and Immunity.

[27]  Michael Bienert,et al.  Optimization of the antimicrobial activity of magainin peptides by modification of charge , 2001, FEBS letters.

[28]  M. Burdick,et al.  Cutting Edge: IFN-Inducible ELR− CXC Chemokines Display Defensin-Like Antimicrobial Activity1 , 2001, The Journal of Immunology.

[29]  N. Cianciotto,et al.  Identification of Legionella pneumophila rcp, a pagP-Like Gene That Confers Resistance to Cationic Antimicrobial Peptides and Promotes Intracellular Infection , 2001, Infection and Immunity.

[30]  Hongjian Liu,et al.  Identification of Proteus mirabilisMutants with Increased Sensitivity to Antimicrobial Peptides , 2001, Antimicrobial Agents and Chemotherapy.

[31]  J. Florin-Christensen,et al.  A unique phospholipid organization in bovine erythrocyte membranes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Michael Otto,et al.  Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.

[33]  T. Unger,et al.  The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action. , 2001, Biochemistry.

[34]  R. Hancock,et al.  Synergistic Interactions between Mammalian Antimicrobial Defense Peptides , 2001, Antimicrobial Agents and Chemotherapy.

[35]  E. Pauwels,et al.  99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  T. Tachi,et al.  Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue. , 2001, Biopolymers.

[37]  Eduardo A. Groisman,et al.  The Pleiotropic Two-Component Regulatory System PhoP-PhoQ , 2001, Journal of bacteriology.

[38]  I. del Castillo,et al.  Construction and Characterization of Mutations at Codon 751 of the Escherichia coli gyrB Gene That Confer Resistance to the Antimicrobial Peptide Microcin B17 and Alter the Activity of DNA Gyrase , 2001, Journal of bacteriology.

[39]  S. Lovas,et al.  The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.

[40]  T. McIntosh,et al.  The e¡ect of ethanol on the phase transition temperature and the phase structure of monounsaturated phosphatidylcholines , 2001 .

[41]  S. Miller,et al.  Salmonella: a model for bacterial pathogenesis. , 2001, Annual review of medicine.

[42]  R. Hancock,et al.  Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. , 2000, Biochemistry.

[43]  R. Hancock,et al.  Interactions of Bacterial Cationic Peptide Antibiotics with Outer and Cytoplasmic Membranes ofPseudomonas aeruginosa , 2000, Antimicrobial Agents and Chemotherapy.

[44]  A. Bayer,et al.  Thrombin-Induced Platelet Microbicidal Protein Susceptibility Phenotype Influences the Outcome of Oxacillin Prophylaxis and Therapy of Experimental Staphylococcus aureus Endocarditis , 2000, Antimicrobial Agents and Chemotherapy.

[45]  K. Matsuzaki,et al.  Polar Angle as a Determinant of Amphipathic α-Helix-Lipid Interactions: A Model Peptide Study , 2000 .

[46]  A. Peschel,et al.  The d-Alanine Residues ofStaphylococcus aureus Teichoic Acids Alter the Susceptibility to Vancomycin and the Activity of Autolytic Enzymes , 2000, Antimicrobial Agents and Chemotherapy.

[47]  R I Lehrer,et al.  Crystallization of antimicrobial pores in membranes: magainin and protegrin. , 2000, Biophysical journal.

[48]  Samuel I. Miller,et al.  A PhoP-Regulated Outer Membrane Protease of Salmonella enterica Serovar Typhimurium Promotes Resistance to Alpha-Helical Antimicrobial Peptides , 2000, Journal of bacteriology.

[49]  M. Skurnik,et al.  Temperature‐regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia , 2000, Molecular microbiology.

[50]  P. Skatrud,et al.  The role of ABC transporters from Aspergillus nidulans in protection against cytotoxic agents and in antibiotic production , 2000, Molecular and General Genetics MGG.

[51]  J. Tam,et al.  Membranolytic selectivity of cystine-stabilized cyclic protegrins. , 2000, European journal of biochemistry.

[52]  A. Bayer,et al.  In Vitro Resistance of Staphylococcus aureus to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Alterations in Cytoplasmic Membrane Fluidity , 2000, Infection and Immunity.

[53]  S. White,et al.  Formation and Characterization of a Single Trp-Trp Cross-link in Indolicidin That Confers Protease Stability without Altering Antimicrobial Activity* , 2000, The Journal of Biological Chemistry.

[54]  R. Bals,et al.  Bacterial Phosphorylcholine Decreases Susceptibility to the Antimicrobial Peptide LL-37/hCAP18 Expressed in the Upper Respiratory Tract , 2000, Infection and Immunity.

[55]  E. Pauwels,et al.  Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations , 2000, European Journal of Nuclear Medicine.

[56]  F. Oppenheim,et al.  Candida albicans Mutants Deficient in Respiration Are Resistant to the Small Cationic Salivary Antimicrobial Peptide Histatin 5 , 2000, Antimicrobial Agents and Chemotherapy.

[57]  K. Matsuzaki,et al.  Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study. , 2000, Biophysical journal.

[58]  H. Vogel,et al.  Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold. , 1999, Biochemistry.

[59]  B. de Kruijff,et al.  The lantibiotic nisin, a special case or not? , 1999, Biochimica et biophysica acta.

[60]  R. Nagaraj,et al.  Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. , 1999, Biochimica et biophysica acta.

[61]  M. Dathe,et al.  Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. , 1999, Biochimica et biophysica acta.

[62]  S. Blondelle,et al.  Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. , 1999, Biochimica et biophysica acta.

[63]  H. Vogel,et al.  Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.

[64]  K. Matsuzaki Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.

[65]  S. Miller,et al.  Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. , 1999, Science.

[66]  A. Bayer,et al.  Plasmid-Mediated Resistance to Thrombin-Induced Platelet Microbicidal Protein in Staphylococci: Role of theqacA Locus , 1999, Antimicrobial Agents and Chemotherapy.

[67]  G. Molle,et al.  Correlation between anti-bacterial activity and pore sizes of two classes of voltage-dependent channel-forming peptides. , 1999, Biochimica et biophysica acta.

[68]  Y. Shai,et al.  Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. , 1999, The Biochemical journal.

[69]  R. Hancock,et al.  Salt-Resistant Alpha-Helical Cationic Antimicrobial Peptides , 1999, Antimicrobial Agents and Chemotherapy.

[70]  Zhimin Zhou,et al.  Lipid A Modifications Characteristic of Salmonella typhimurium Are Induced by NH4VO3 inEscherichia coli K12* , 1999, The Journal of Biological Chemistry.

[71]  Zhimin Zhou,et al.  Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate. , 1999, The Journal of biological chemistry.

[72]  R. Benz,et al.  Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. , 1999, Biochemistry.

[73]  B D Sykes,et al.  Dissociation of Antimicrobial and Hemolytic Activities in Cyclic Peptide Diastereomers by Systematic Alterations in Amphipathicity* , 1999, The Journal of Biological Chemistry.

[74]  A. Bayer,et al.  Antimicrobial peptides from platelets. , 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[75]  G. Khuller,et al.  Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37Ra , 1999, Archives of Microbiology.

[76]  H. Kalbacher,et al.  Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides* , 1999, The Journal of Biological Chemistry.

[77]  T. Abee,et al.  The Cellular Target of Histatin 5 on Candida albicans Is the Energized Mitochondrion* , 1999, The Journal of Biological Chemistry.

[78]  Samuel I. Miller,et al.  How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. , 1999, The Journal of infectious diseases.

[79]  P. Dhurjati,et al.  Cecropins induce the hyperosmotic stress response in Escherichia coli. , 1998, Biochimica et biophysica acta.

[80]  V. Fowler,et al.  In Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein among Clinical Bacteremic Isolates of Staphylococcus aureus Correlates with an Endovascular Infectious Source , 1998, Antimicrobial Agents and Chemotherapy.

[81]  R. Gross,et al.  The Lipopolysaccharide of Bordetella bronchiseptica Acts as a Protective Shield against Antimicrobial Peptides , 1998, Infection and Immunity.

[82]  K. Matsuzaki,et al.  Magainins as paradigm for the mode of action of pore forming polypeptides. , 1998, Biochimica et biophysica acta.

[83]  W. Wang,et al.  The Dependence of Membrane Permeability by the Antibacterial Peptide Cecropin B and Its Analogs, CB-1 and CB-3, on Liposomes of Different Composition* , 1998, The Journal of Biological Chemistry.

[84]  Samuel I. Miller,et al.  Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides , 1998, Cell.

[85]  M. Zasloff,et al.  Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. , 1998, Biochemistry.

[86]  R. Proctor,et al.  Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[87]  P. Lasch,et al.  The influence of poly-(L-lysine) and porin on the domain structure of mixed vesicles composed of lipopolysaccharide and phospholipid: an infrared spectroscopic study. , 1998, Biophysical journal.

[88]  G. Georgiou,et al.  Identification of OmpT as the Protease That Hydrolyzes the Antimicrobial Peptide Protamine before It Enters Growing Cells ofEscherichia coli , 1998, Journal of bacteriology.

[89]  C. B. Park,et al.  Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.

[90]  S. Miller,et al.  PmrA–PmrB‐regulated genes necessary for 4‐aminoarabinose lipid A modification and polymyxin resistance , 1998, Molecular microbiology.

[91]  W. Shafer,et al.  Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[92]  H. Sahl,et al.  The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II , 1998, Antimicrobial Agents and Chemotherapy.

[93]  W. Foss,et al.  Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. , 1998, The Journal of clinical investigation.

[94]  J. Hoffmann,et al.  Cysteine-rich antimicrobial peptides in invertebrates. , 1998, Biopolymers.

[95]  R. B. Merrifield,et al.  Synthesis and antibacterial action of cecropin and proline-arginine-rich peptides from pig intestine. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[96]  E. Krause,et al.  Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment , 1997, FEBS letters.

[97]  M. Yeaman The role of platelets in antimicrobial host defense. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[98]  E. Groisman,et al.  Regulation of polymyxin resistance and adaptation to low-Mg2+ environments , 1997, Journal of bacteriology.

[99]  R. Epand,et al.  Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. , 1997, Biochemistry.

[100]  R. Epand,et al.  Structural aspects of the interaction of peptidyl-glycylleucine-carboxyamide, a highly potent antimicrobial peptide from frog skin, with lipids. , 1997, European journal of biochemistry.

[101]  A. Cheung,et al.  Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus , 1997, Infection and immunity.

[102]  N. Fujii,et al.  Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. , 1997, Biochimica et biophysica acta.

[103]  E. Krause,et al.  Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. , 1997, Biochemistry.

[104]  H. Wenschuh,et al.  Influence of proline position upon the ion channel activity of alamethicin. , 1997, Biophysical journal.

[105]  O. Oishi,et al.  Conformations and orientations of aromatic amino acid residues of tachyplesin I in phospholipid membranes. , 1997, Biochemistry.

[106]  S. Stumpe,et al.  Requirement of a large K+-uptake capacity and of extracytoplasmic protease activity for protamine resistance of Escherichia coli , 1997, Archives of Microbiology.

[107]  N. Fujii,et al.  Modulation of magainin 2-lipid bilayer interactions by peptide charge. , 1997, Biochemistry.

[108]  M. Dathe,et al.  Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides , 1997, FEBS letters.

[109]  R. Hancock,et al.  Peptide antibiotics , 1997, The Lancet.

[110]  S. Miller,et al.  PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance , 1996, Journal of bacteriology.

[111]  S J Ludtke,et al.  Membrane pores induced by magainin. , 1996, Biochemistry.

[112]  T. Ganz,et al.  Endogenous Vertebrate Antibiotics , 1996 .

[113]  W. Maloy,et al.  Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers. , 1996, Biochemistry.

[114]  E. Krause,et al.  Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. , 1996, Biochemistry.

[115]  M. Ghannoum,et al.  Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis , 1996, Infection and immunity.

[116]  H. Vogel,et al.  Ion pair formation of phosphorylated amino acids and lysine and arginine side chains: A theoretical study , 1996, Proteins.

[117]  R. Proctor,et al.  Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. , 1996, The Journal of infectious diseases.

[118]  J P Roussel,et al.  Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[119]  T. Ganz,et al.  Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides. , 1996, Annals of the New York Academy of Sciences.

[120]  D. McCarthy,et al.  Comparison of the effects of hydrophobicity, amphiphilicity, and α‐helicity on the activities of antimicrobial peptides , 1995, Proteins.

[121]  G M Anantharamaiah,et al.  Molecular basis for prokaryotic specificity of magainin-induced lysis. , 1995, Biochemistry.

[122]  H. Westerhoff,et al.  Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes. , 1995, European journal of biochemistry.

[123]  I. Kilpeläinen,et al.  Increased substitution of phosphate groups in lipopolysaccharides and lipid A of polymyxin-resistant mutants of Salmonella typhimurium and Escherichia coli. , 1995, Progress in clinical and biological research.

[124]  A. Mor,et al.  The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. , 1994, The Journal of biological chemistry.

[125]  R. Proctor,et al.  Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. , 1994, Infectious agents and disease.

[126]  S. Miller,et al.  Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci , 1994, Infection and immunity.

[127]  M. Ruzek,et al.  Degradation of C3 by Streptococcus pneumoniae. , 1994, The Journal of infectious diseases.

[128]  J. Johansson,et al.  Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide. , 1994, European journal of biochemistry.

[129]  A. Bayer,et al.  In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates , 1994, Antimicrobial Agents and Chemotherapy.

[130]  T. Ganz,et al.  Defensins: a family of antimicrobial and cytotoxic peptides. , 1994, Toxicology.

[131]  I. Kilpeläinen,et al.  Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin‐resistant pmrA mutants of Salmonella typhimurium: a 31P‐NMR study , 1994, Molecular microbiology.

[132]  S. Opella,et al.  Structure and orientation of the antibiotic peptide magainin in membranes by solid‐state nuclear magnetic resonance spectroscopy , 1993, Protein science : a publication of the Protein Society.

[133]  H. G. Boman,et al.  Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine , 1993, Infection and immunity.

[134]  H. Westerhoff,et al.  Electric potentiation, cooperativity, and synergism of magainin peptides in protein-free liposomes. , 1993, Biochemistry.

[135]  R A Houghten,et al.  Design of model amphipathic peptides having potent antimicrobial activities. , 1992, Biochemistry.

[136]  T. Quan,et al.  A surface protease and the invasive character of plague. , 1992, Science.

[137]  Y. Arakawa,et al.  Mechanisms of antibacterial action of tachyplesins and polyphemusins, a group of antimicrobial peptides isolated from horseshoe crab hemocytes , 1992, Antimicrobial Agents and Chemotherapy.

[138]  I. Shalit,et al.  Augmentation of the antibacterial activity of magainin by positive-charge chain extension , 1992, Antimicrobial Agents and Chemotherapy.

[139]  N. Fujii,et al.  Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. , 1991, Biochimica et biophysica acta.

[140]  M. Sansom The biophysics of peptide models of ion channels. , 1991, Progress in biophysics and molecular biology.

[141]  I. Shalit,et al.  All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance , 1990, FEBS letters.

[142]  R. B. Merrifield,et al.  All-D amino acid-containing channel-forming antibiotic peptides. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[143]  K. Gable,et al.  Raman spectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa. , 1990, Biochemistry.

[144]  K. Prasad,et al.  Seminalplasmin, an antimicrobial protein from bovine seminal plasma, inhibits peptidoglycan synthesis in Escherichia coli. , 1990, FEMS microbiology letters.

[145]  T. Ganz,et al.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. , 1989, The Journal of clinical investigation.

[146]  H. Westerhoff,et al.  Magainin 2 amide and analogues Antimicrobial activity, membrane depolarization and susceptibility to proteolysis , 1989, FEBS letters.

[147]  N. Fujii,et al.  Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. , 1989, Biochimica et biophysica acta.

[148]  L. Kowalski About electrostatic shielding , 1989 .

[149]  E. Groisman,et al.  A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. , 1989, Science.

[150]  T. Nishihara,et al.  Purification, characterization, and primary structure of Escherichia coli protease VII with specificity for paired basic residues: identity of protease VII and OmpT , 1988, Journal of bacteriology.

[151]  W. Shafer,et al.  Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granulocytes , 1986, Infection and immunity.

[152]  D. Minnikin,et al.  Polar lipid and isoprenoid quinone composition in the classification of Staphylococcus. , 1984, Journal of general microbiology.

[153]  M. Vaara,et al.  Susceptibility of gram-negative bacteria to polymyxin B nonapeptide , 1984, Antimicrobial Agents and Chemotherapy.

[154]  D. Eisenberg Three-dimensional structure of membrane and surface proteins. , 1984, Annual review of biochemistry.

[155]  E. Granados,et al.  Conformation and aggregation of melittin: dependence on pH and concentration. , 1982, Biochemistry.

[156]  H. Heymann,et al.  Resistance of Spheroplasts and Whole Cells of Pseudomonas cepacia to Polymyxin B , 1978, Antimicrobial Agents and Chemotherapy.

[157]  H Lecar,et al.  Electrically gated ionic channels in lipid bilayers , 1977, Quarterly Reviews of Biophysics.